Canadian start-up PatoBios and assay provider DiscoverX have forged a scientific collaboration to combine their flagship technologies and develop a high-throughput live-cell assay for GPCR screening, CBA News has learned.

The deal may help PatoBios exploit the high-throughput potential of its patent-pending GPCR screening assay, which has thus far only been used in lower-throughput academic research settings, while possibly giving DiscoverX another cellular drug-discovery assay to add to its growing portfolio in this area.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.